PD-1 up-regulation on activated T cells in circulation and in the tumour microenvironment has been well documented, as has the upregulation of its ligand, PD-L1, by tumour cells and several immune cell subsets (reviewed by Ostrand-Rosenberg [53]). Here, CD274 is linked to neoplasm.